Long-term human survival cohorts and Phase 3 prevention trials covering UKPDS 34 / TAME Metformin AMPK longevity pathways, muscle protein synthesis across eight decades of life, and adult vaccine coadministration trials. Explore 817 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
These results suggest that increasing the dose of metformin improves serum MDA-LDL levels in type 2 diabetes.
Eculizumab single-drug treatment provides effective long-term relapse prevention, relieving the chronic immunosuppression burden in patients with AQP4-IgG + NMOSD..
Post-transplant survival, non-relapse mortality, and relapse were not different between arms.
Our compared against a dummy pill (placebo) randomized trial suggests that liraglutide has renoprotective effects on top of multifactorial treatment, including RAS-inhibition, in patients with type 2 diabetes and albuminuria.
The lack of significant effect demonstrated by these data suggests a limited role for amlodipine in patients with ischemic cardiomyopathy, although it may prove beneficial in those with nonischemic disease.
Montelukast and CoQ10 were tolerable and showed potential benefits as add on therapies in sepsis management.
This prospective, comparative clinical study demonstrated that the application of PRP in conjunction with pharmacological support during FUE treatment for AGA resulted in improved follicle survival rates, hair growth rates,...
Intention-to-treat analyses revealed no within-group changes or differences in change between the groups for any measures of physical activity or sedentary behaviour at neither 6 nor 13 weeks.
Our findings reveal that GLP-1 receptor activation modulates associative learning in people with obesity via its central effects within the mesoaccumbens pathway.
Male patients with metastatic RCC and hypogonadism receiving testosterone had less fatigue and better symptom control during targeted therapy.
Nivolumab plus ipilimumab had modest efficacy for papillary kidney cell carcinoma compared with that for clear cell kidney cell carcinoma.
In addition, the results showed that both mixtures reduced the release of IL-1β and IL-6.
Observed effects were more pronounced in Phase 2 due to the period effect and loss of blinding.
Clinical Trial Registration URL : http://www.clinicaltrials.gov .
The nurse-led multicomponent exercise intervention was safe and feasible and showed favourable trends in muscle strength and physical function, although statistically significant between-group differences were not retained after correction for multiple comparisons.
We observed decreased CTX, decreased PINP and increased lumbar spine BMD after two years of testosterone treatment.
TRT normalized serum testosterone levels, improved blood sugar control and endothelial function while exerting no ill effects on the study population.
Longitudinal muscle mass loss emerged as a predictive factor for both OS and HRQoL in aPDAC patients undergoing chemotherapy, while a low SMI at diagnosis did not provide prognostic value.
Limited survival benefit in the Japanese subgroup can be attributed to small patient numbers and to baseline imbalances observed between treatment arms, with more patients in the venetoclax plus low-dose cytarabine arm presenting.
Protein, adenovirus-vector or mRNA vaccine boosters were equally well tolerated and immunogenic against ancestor SARS-CoV-2 and Omicron sub-lineages in fully primed adults with 0-2 prior boosters.
Perioperative mFOLFOX6 may be an insufficient treatment to improve survival of lower rectal cancer with lateral pelvic lymph node metastasis.
Aortic blood pressures (median systolic 115 mm Hg and diastolic 76 mm Hg) and augmentation index (median 33%) did not differ among women across prior treatment assignment.
In this 4-year prospective assessment of recently menopausal women, MHT did not significantly alter RHI when compared to placebo.
The results imply that telmisartan could treat both the blood flow and heart rate and metabolic aberrations seen in patients with the metabolic syndrome, improving insulin resistance and glucose intolerance at least partly...
Conclusion: PSMA PET/CT upstaged 17% of patients, which allowed for more accurate radiotherapy planning.
Tumor resectability of pancreatic cancer staged as unresectable at primary diagnosis should be reassessed after neoadjuvant treatment.
Ezetimibe coadministered with atorvastatin or simvastatin in patients with HoFH produced clinically important LDL-C reductions compared with best current therapy.
NEW & NOTEWORTHY During a test of lower limb dynamic exercise, individuals with Down syndrome (DS) demonstrate reduced femoral artery blood flow and vascular conductance to the active limb and marginal augmentation of blood...
These findings suggest that in healthy postmenopausal women, 12 weeks of aerobic training is effective in eliciting favorable heart and blood vessel adaptations, regardless of the presence of short-term HT.
Greater muscle mass recruitment did not result in superior blood-pressure-lowering effects, suggesting that the chronic blood pressure response to isometric exercise is not determined solely by the amount of muscle mass involved.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
